RMD ResMed Inc.
ResMed Inc. (RMD) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $1.8M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $222.44 | $1.1M | 466,256 −1.1% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 970 | $234.73 | $227.7K | 51,803 −1.8% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $205.69 | $1.0M | 466,256 −1.1% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 8,000 | $225.00 | $1.8M | 52,773 −13.2% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $218.55 | $1.1M | 466,223 −1.1% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $193.96 | $968.1K | 466,256 −1.1% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $207.82 | $1.0M | 466,223 −1.1% of holding | |
| Farrell Michael J. | Chairman and CEO | Sell 10b5-1 | 4,991 | $225.50 | $1.1M | 466,223 −1.1% of holding | |
| FARRELL PETER C | Director | Sell 10b5-1 | 2,000 | $225.00 | $450.0K | 60,773 −3.2% of holding | |
| Sandercock Brett | Chief Financial Officer | Sell 10b5-1 | 1,000 | $224.31 | $224.3K | 83,495 −1.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.